KU Hematology & Medical Oncology Review 2019

 

Lung
15:47

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of Neoadjuvant Therapy and Checkpoint Inhibitors

FEATURING Corey Langer
  • 1,609 views
  • August 2, 2019
  • 6
22:33

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of Recurrent / Metastatic NSCLC: Wild Type, KN001 5 yr Data, Insights on TMB, STK11, & MYSTI(AL), Maintenance and Oncologenic Drivers

FEATURING Corey Langer
  • 893 views
  • August 2, 2019
  • 4